/Steris%20Plc%20logo%20and%20chart-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Mentor, Ohio-based STERIS plc (STE) provides infection prevention products and services worldwide. With a market cap of $22.2 billion, the company operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences.
STE is scheduled to report its Q2 earnings on Tuesday, August 5. Ahead of the event, analysts expect the company to report a profit of $2.32 per share, representing a 14.3% increase from $2.03 per share in the same quarter of the previous year. The company has surpassed or matched Wall Street's bottom-line estimates in each of the past four quarters.
For fiscal 2025, analysts expect STE to report earnings of $10.13 per share, up 9.9% from $9.22 in fiscal 2024. Moreover, the earnings are expected to rise 8.1% year-over-year to $10.95 per share in fiscal 2026.
STE stock has grown 3.8% over the past 52 weeks, lagging behind the S&P 500 Index's ($SPX) 10.9% gain but outperforming the Health Care Select Sector SPDR Fund’s (XLV) 10.3% decline over the same time frame.
STE shares grew 8.5% in the trading session following the release of its Q4 earnings on May 14. The company’s revenue increased 4.3% to $1.5 billion, surpassing the Street’s estimates, mainly driven by a strong growth in its Healthcare and AST segments. Moreover, its adjusted EPS grew 6.2% year-over-year to $2.74 and surpassed the consensus estimates by 5.8%.
Analysts’ consensus opinion on STE stock is highly optimistic, with an overall “Strong Buy” rating. Out of eight analysts covering the stock, six advise a “Strong Buy” rating and two recommend a “Hold.”
The stock’s average analyst price target is $272.14, indicating an 18.9% potential upside from the current levels.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
